Status:
UNKNOWN
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
Lead Sponsor:
Helio Genomics
Conditions:
Cancer
Liver Cirrhosis
Eligibility:
All Genders
18+ years
Brief Summary
To acquire blood samples from subjects for various purposes, including: i) determining the sensitivity and specificity of select DNA methylation markers for the detection of various types of cancer, i...
Detailed Description
Whole blood, plasma, and/or serum specimens will be collected from patients with active cancer, patients in cancer remission, patients diagnosed with benign disease, and healthy volunteers. These bloo...
Eligibility Criteria
Inclusion
- 1.1 Age 18 years or older.
- 1.2 A diagnosis of cancer, cancer remission, benign disease (benign tumor, diabetes, liver cirrhosis, chronic hepatitis B or hepatitis C virus infection, Chronic obstructive pulmonary disease, etc.) or apparently healthy volunteers. .
Exclusion
- 2.1 Patients that are unwilling or unable to sign the Informed Consent Form will be excluded.
- 2.2 Approximately 50 mL of blood will be drawn from participants within an 8-week period under this protocol. Patients that have already given 50 mL of blood within this time frame will be excluded.
Key Trial Info
Start Date :
May 21 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT05181826
Start Date
May 21 2019
End Date
December 1 2025
Last Update
June 14 2024
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Torrance Memorial Physician Network - Cancer Care
Redondo Beach, California, United States, 90277
2
Allina Health, Virginia Piper Cancer Institute
Coon Rapids, Minnesota, United States, 55433
3
Virginia Piper Cancer Institute Mercy Hospital-Unity Campus
Fridley, Minnesota, United States, 55432
4
VPCI Oncology Research
Minneapolis, Minnesota, United States, 55407